Harald Reinhart - Aug 23, 2021 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Role
Chief Medical Officer
Signature
/s/ Bruce A. Blefeld
Stock symbol
ZLAB
Transactions as of
Aug 23, 2021
Transactions value $
-$1,939,040
Form type
4
Date filed
8/25/2021, 05:47 PM
Previous filing
Jul 15, 2021
Next filing
Sep 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZLAB Ordinary Shares Options Exercise $144K +8K $17.99 8K Aug 23, 2021 Direct F1
transaction ZLAB Ordinary Shares Sale -$1.08M -8K -100% $135.00* 0 Aug 23, 2021 Direct F1
transaction ZLAB Ordinary Shares Options Exercise $144K +8K $17.99 8K Aug 24, 2021 Direct F1
transaction ZLAB Ordinary Shares Sale -$1.15M -8K -100% $143.36* 0 Aug 24, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -8K -17.39% $0.00 38K Aug 23, 2021 Ordinary Shares 8K $17.99 Direct F1, F2
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -8K -21.05% $0.00 30K Aug 24, 2021 Ordinary Shares 8K $17.99 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 The options vest in equal annual installments over five years beginning on 11/16/2019, the first anniversary of the date of grant.